George Richards Minot

Also found in: Medical.

Minot, George Richards

(mī`nət), 1885–1950, American physician and pathologist, b. Boston, M.D. Harvard, 1912. From 1928 to 1948 he was professor of medicine at Harvard and director of the Thorndike Memorial Laboratory, Boston City Hospital. He specialized in diseases of the blood, and for his research on the value of liver in treating pernicious anemia he shared with W. P. Murphy and G. H. Whipple the 1934 Nobel Prize in Physiology or Medicine.


See biography by F. M. Rackemann (1956).

Minot, George Richards


Born Dec. 2, 1885, in Boston; died Feb. 25, 1950, in Brooklyn. American specialist in pathophysiology and therapeutic hematology.

In 1912, Minot graduated from the medical school of Harvard University and became a professor at the university in 1928. His principal works were devoted to the pathophysiology and clinical treatment of anemic states. He developed a method called the liver treatment of malignant anemia, which stimulated research on the mechanism of development of this disease and led to the discovery of the “antipernicious” vitamin B12. For his development of the therapeutic use of liver, Minot (together with W. Murphy and G. H. Whipple) was awarded a Nobel Prize in 1934.


“Treatment of Pernicious Anemia by a Special Diet.” Journal of the American Medical Association, 1926, vol. 87, no. 7, pp. 470-76. (With W. P. Murphy.)
“Treatment of Pernicious Anemia With Liver Extract …” American Journal of the Medical Sciences, 1928, vol. 175, no. 5, pp. 599-622.


Kruif, P. de. Bor’ba so smert’iu. [Leningrad] 1936. (Translated from English.)
References in periodicals archive ?
Although the inflammatory response is a key part of our immune system and an important means of protection and tissue repair in response to infection or injury, under certain conditions of metabolic dysfunction, this response is activated even in the absence of foreign pathogens," Kahn, Vice Chair of the Department of Medicine at BIDMC and George Richards Minot Professor of Medicine at Harvard Medical School, said.
Rosenblatt, who is Chief of the Division of Bone and Mineral Research at BIDMC and the George Richards Minot Professor of Medicine at Harvard Medical School.
AMPK is an evolutionarily conserved 'fuel gauge,'" said senior author Barbara Kahn, MD, a scientist in the Division of Endocrinology, Diabetes and Metabolism at BIDMC and the George Richards Minot Professor of Medicine at Harvard Medical School.